bleeding.
Conditions
Interventions
Intervention 1: Intervention group: patients will receive Clonidine 200 mcg oral tablet, 90 minutes before surgery. Intervention 2: Intervention group: Patients in Group dexmedetomidine will be receiv
Sponsors
Oroumia University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Aged 20-60 years old American Society of Anesthesiologists physical status classification I,II General anesthesia
Exclusion criteria
Exclusion criteria: Patients with diabetes mellitus Coagulation problems Liver or kidney failure Cerebrovascular disease High blood pressure Asthma Chronic obstructive pulmonary disease Severe end organ damage Psychosis Patients receiving antipsychotic medication Hypersensitivity to dexmedetomidine and clonidine Drug abusers Use of beta blockers drugs Heart rate less than 55 beats per minute
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amount of bleeding. Timepoint: during surgery. Method of measurement: Measuring the amount of blood inside the suction device and the gases used.;Quality of the surgical field. Timepoint: During surgery. Method of measurement: Boezaart scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean arterial pressure. Timepoint: Every 5 minutes during the surgery. Method of measurement: Non invasive pressure gauge.;Mean pulse Rate. Timepoint: Every 5 minutes during the surgery. Method of measurement: Electrocardiogram. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShahryar Sane
Oroumia University of Medical Sciences
Outcome results
None listed